Bookmark

Add to MyYahoo RSS

Merck & Co. News

News on Merck & Co. (Ticker: MRK) continually updated from thousands of sources around the net.

9 hrs ago | Value Line

Drug Roundup - " April 17, 2014

There have been several noteworthy developments in the drug space recently, which will likely have a material impact on the companies in this sector and the markets they serve.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Teva Pharmaceutical Industries, Merck , Eli Lilly, Bristol Myers Squibb

13 hrs ago | BioSpace

FDA OKs Merck & Co., Inc. Tablet To Reduce Ragweed Allergies

FDA Approves Merck's RAGWITEKa Sublingual Tablet as Immunotherapy to Treat Short Ragweed Pollen-Induced Allergic Rhinitis with or without Conjunctivitis in Adults RAGWITEK is the First and Only FDA Approved Sublingual Allergen Immunotherapy Tablet Indicated for the Treatment of Short Ragweed Pollen Allergies WHITEHOUSE STATION, N.J.-- --Merck , ... (more)

Comment?

Related Topix: Biotech, Merck , Food and Drug Administration, Medicine, Healthcare Industry, Conjunctivitis, Health, Allergy, Immunology, Biology, Science

17 hrs ago | ABC News

FDA OKs Merck Tablet to Reduce Ragweed Allergies

U.S. regulators have again approved a Merck & Co. tablet for gradually reducing seasonal allergies, this time for ragweed pollen.

Comment?

Related Topix: Biotech, Merck , Medicine, Healthcare Industry, Whitehouse Station, NJ

Wed Apr 16, 2014

Business Journal

Clinipace becomes a 'preferred provider,' starts acting like a big CRO

By reaching a preferred provider deal with a mid-market drug developer, Clinipace is starting to act like a much bigger contract research organization.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, GlaxoSmithKline, Merck

Tue Apr 15, 2014

KDWN

FDA OKs Merck tablet to reduce grass allergies

Merck & Co. says the Food and Drug Administration has approved its new tablet for grass allergies, Grastek, for patients five to 65 years old.

Comment?

Related Topix: Biotech, Merck , Medicine, Healthcare Industry, Food and Drug Administration, Whitehouse Station, NJ

BioSpace

FDA Approves Merck & Co., Inc.'s Grass Pollen Pill GRASTEK

FDA Approves Merck's GRASTEKA Sublingual Tablet as Immunotherapy to Treat Grass Pollen-Induced Allergic Rhinitis with or without Conjunctivitis in Children and Adults WHITEHOUSE STATION, N.J.-- --Merck , known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved GRASTEKA Tablet for ... (more)

Comment?

Related Topix: Medicine, Pollen, Health, Food and Drug Administration, Biotech, Merck , Healthcare Industry, Conjunctivitis, Allergy

Mon Apr 14, 2014

AmericanBankingNews.com

Merck & Co. Given New $61.00 Price Target at Jefferies Group

Jefferies Group's price target would indicate a potential upside of 9.08% from the stock's previous close.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Merck , Investment Banking, Financial Services, Jefferies Group, Investment Services

Fri Apr 11, 2014

BioSpace

Merck & Co., Inc.??'s Investigational Chronic Hepatitis C Combination ...

Merck , known as MSD outside of the United States and Canada, today announced interim results from the ongoing C-WORTHy study, a multi-arm Phase 2 clinical trial evaluating the efficacy and safety of an all-oral, once-daily regimen combining MK-5172, an investigational hepatitis C virus NS3/4A protease inhibitor, and MK-8742, an investigational HCV ... (more)

Comment?

Related Topix: Biotech, Merck , Medicine, Healthcare Industry

Thu Apr 10, 2014

AmericanBankingNews.com

Merck & Co. Target of Unusually High Options Trading

Merck & Co. was the target of some unusual options trading activity on Thursday.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Merck

Barron's

Merck's Hepatitis C Drug May Boost Stock

Early Thursday, Merck & Co. announced that a pair of its hepatitis C treatments -- MK-5172 and MK-8742 -- cured 98% of newly treated patients in a midstage clinical trial presented at the European Association for the Study of the Liver in London.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Hepatitis, Merck , Health

Barron's

Gilead Sciences: How Big a Threat is Merck?

For those wondering if Merck's hepatitis C drug would prove effective, the answer was a resounding yes.

Comment?

Related Topix: Biotech, Medicine, Gilead Sciences, Healthcare Industry, Merck , Hepatitis, Health, Achillion Pharmaceuticals, Pharmaceuticals

Wed Apr 09, 2014

BayStreet.ca

BlackBerry CEO May Consider Exiting Handset Business; Celgene...

Shares of Merck & Co. closed up 3.74% on Wednesday with about 16 million shares traded.

Comment?

Related Topix: Biotech, Celgene, Medicine, Healthcare Industry, Merck , Financial Markets, Biomira

BioSpace

Trialnetworks Wins Disruptive Technology And Innovator Of The Year...

April 8, 2014 - TrialNetworks and its Clinical Trial Optimization System won the Disruptive Innovator and Technology of the Year award from Partnerships in Clinical Trials 2014.

Comment?

Related Topix: Emerging Technology, Las Vegas, NV, Biotech, Medicine, Discovery Partners International, Infinity Pharmaceuticals, Healthcare Industry

SchaeffersResearch.com

Stocks Soar After Fed Minutes; Dow Jumps 181 Points

"The bounce that started yesterday continued in a big way today," noted Schaeffer's Senior Technical Strategist Ryan Detrick, CMT.

Comment?

Related Topix: Financial Markets, Biotech, Merck , Medicine, Healthcare Industry, Opinion, Day Trading, Personal Finance

MarketNewsVideo

Dow Movers: T, MRK

In early trading on Wednesday, shares of Merck & Co. topped the list of the day's best performing Dow Jones Industrial Average components, trading up 1.6%.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Merck , Business News, Video

Emirates News Agency

MSD and Julphar team up to address patients' needs in the region

WAM DUBAI, 9th April, 2014 -- MSD, the global healthcare company known as Merck and Co within the US, and Julphar, a U.A.E.-based pharmaceutical company, today signed a landmark five-year licensing agreement.

Comment?

Related Topix: Biotech, Merck , Medicine, Healthcare Industry

Tue Apr 08, 2014

The Jersey Journal

Frontrunner emerges in bid for Merck's OTC health unit

In the battle between global consumer-health companies for a multibillion dollar foot-care, allergy and sun-tan lotion business, Reckitt Benckiser Group has advantages that rivals will be hard pressed to match.

Comment?

Related Topix: Biotech, Merck , Medicine, Healthcare Industry, Allergy, Health, Whitehouse Station, NJ, Claritin, Loratadine (generic), Sundown, Bullfrog, Sunscreens (generic)

Mon Apr 07, 2014

Investopedia

This Biotech Market Could Quadruple -- 3 Stocks To Profit

In some respects, this is a golden age for pharmaceuticals. Thousands of medical researchers are making major clinical progress in the fight to treat cancer, heart disease and other afflications.

Comment?

Related Topix: Biotech, Merck , Startups, Medicine, Vaccine Company, Healthcare Industry, Bain & Company, HPV, Health, Pfizer

GlobeNewswire

Bionomics Features at American Association for Cancer Research Annual Meeting

Bionomics Limited is delivering three poster presentations at the 105th Annual American Association for Cancer Research meeting at the San Diego Convention Center this week.

Comment?

Related Topix: Pancreatic Cancer, Health, Stem Cell Research, Science / Technology, Medicine, Pharmacology, Dartmouth College, Oncology

Fri Apr 04, 2014

AmericanBankingNews.com

Insider Selling: Merck & Co. Insider Unloads 145,225 Shares of Stock

Merck & Co. Insider Bruce N. Kuhlik sold 145,225 shares of the stock in a transaction that occurred on Friday, April 4th.

Comment?

Related Topix: Biotech, Merck , Medicine, Healthcare Industry, Startups, Bain & Company, Vaccine Company

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••
•••